Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo

Biotech Podcasts

show episodes
 
Artwork

1
The Future of Everything

Stanford Engineering

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Weekly
 
Host Russ Altman, a professor of bioengineering, genetics, and medicine at Stanford, is your guide to the latest science and engineering breakthroughs. Join Russ and his guests as they explore cutting-edge advances that are shaping the future of everything from AI to health and renewable energy. Along the way, “The Future of Everything” delves into ethical implications to give listeners a well-rounded understanding of how new technologies and discoveries will impact society. Whether you’re a ...
  continue reading
 
Talking Biotech is a weekly podcast that uncovers the stories, ideas and research of people at the frontier of biology and engineering. Each episode explores how science and technology will transform agriculture, protect the environment, and feed 10 billion people by 2050. Interviews are led by Dr. Kevin Folta, a professor of molecular biology and genomics.
  continue reading
 
"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something ...
  continue reading
 
Artwork

1
Sounds of Science

Charles River

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
Sounds of Science is a monthly podcast about beginnings: how a molecule becomes a drug, how a rodent elucidates a disease pathway, how a horseshoe crab morphs into an infection fighter. The podcast is produced by Eureka, the scientific blog of Charles River, a contract research organization for drug discovery and development. Tune in and begin the journey.
  continue reading
 
Artwork

1
CHI Podcasts

Cambridge Healthtech Podcasts

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
The CHI Podcasts are produced by the Cambridge Healthtech Institute and offer in-depth interviews with research and business leaders from many facets of biotechnology.
  continue reading
 
Artwork

1
Biologize

Phil Richardson

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
Dr Phil Richardson explores how to solve complex problems in strategy, innovation and change management using business models created from biological systems. Based on 3.8 billion years of evolution biological systems can provide a unique, if not counterintuitive way of thinking differently. The approach has been successfully used in product and service development, creating new ways of working, improving collaboration and delivering disruptive change.
  continue reading
 
The Biotech Startups Podcast by Excedr features weekly conversations with founders, scientists, and investors driving biotech innovation. Host Jon Chee dives into the challenges of building biotech startups, from pre-seed to IPO. New episodes every Monday and Thursday.
  continue reading
 
Artwork

1
Inside Biotech

Gabriella Rubert, Daniel Arce, Katherine Merkling, Serena Gao, Bryan Jimenez, Danielle Luu, Stephanie Wu

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
Inside Biotech is an exciting podcast from BCLA, which focuses on the science behind SoCal’s most innovative new biotech companies. This semi-monthly podcast, hosted by Gabriella Rubert, Ph.D. Candidate at UCLA and Podcast Lead at BCLA, is the perfect way for anyone interested in LA’s biotech community to stay informed about current progress and developments. Episodes feature conversations with scientists, entrepreneurs, investors, and more about the cutting-edge science that goes on inside ...
  continue reading
 
Watch the #1 Biotech Podcast in Europe to grow. Hosted by Philip Hemme. 25k monthly views. Free. Guests include Antoine Papiernik @Sofinnova, Werner Lanthaler @Evotec, Ingmar Hoerr @CureVac, Bernat Olle @Vedanta, Johannes Fruehauf @BioLabs, Rodger Novak @CRISPR Tx, Agnete Fredriksen @Nykode, Mike Ward, Thomas Clozel @Owkin, Marc de Garidel @Abivax, Sander van Deventer @VectorY & Forbion, Jens Nielsen @BII, Edwin Moses, Bahija Jallal @Immunocore, and more. Your host Philip animates the conver ...
  continue reading
 
Welcome to Biotech Bulls & Breakthroughs! This brand new podcast from BioPharmCatalyst explores the dynamic world of biotech investing alongside long-time biotech trader Sheff from Sheff Station. Each month, we will be discussing current events in the biotech industry and how these events impact investors, as well as a discussion of upcoming catalysts in the biotech space.
  continue reading
 
Welcome to BIOTECH NATION !!! With understandable interviews requiring no background in science, BTN attracts a wide global audience. From everyday people looking for hope in treatments in development, to bioentrepreneurs interested in the experience of their fellow travelers, to venture capitalists looking for possibilities in cutting-edge breakthroughs, to scientists simply interested in the work of others, BioTech Nation is the voice of human endeavor, driving science to new realities for ...
  continue reading
 
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The B ...
  continue reading
 
Artwork

1
Pharma and BioTech Daily

Pharma and BioTech News

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Daily
 
Pharma & Biotech Daily is a short, AI-generated, human-supervised briefing on what’s important in pharma and biotech. Each weekday we condense key news on pipelines, deals, regulation and strategy into a quick audio update for people who build, run and invest in life sciences. Produced by OWITH.ai, a boutique AI & data studio. Sponsor the show: https://sponsor.owith.ai
  continue reading
 
Grow Everything reveals the world of biology as technology. Hosts Erum Khan and Karl Schmieder interview leaders and influencers biologizing industries with tools like synthetic biology, precision fermentation, bioprospecting, and more. These companies make biomaterials from waste, cosmetics that restore healthy hair and skin, and delicious cultivated foods in a bioreactor and so much more. Join us as we discuss the latest and greatest across biotech, synbio, entrepreneurship, and culture an ...
  continue reading
 
Welcome to the official Labiotech.eu podcast - Beyond Biotech! Each week, we talk about what's happening in the world of biotech, with news and interviews with experts from companies around the world. Join us as we cover the latest news, breakthroughs and innovations shaping the life sciences industry.A new podcast episode is available every Friday. The host is Dylan Kissane.
  continue reading
 
Artwork

1
Biotech Career Coach

Carina Clingman

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly+
 
In the Biotech Career Coach podcast, we share valuable insights and advice for job seekers and career-minded individuals in the biotechnology and life sciences industry. From resume tips to leadership strategies, this podcast will help you navigate your job search and succeed in your career. This podcast is a production of The Collaboratory Career Hub To join our Community or access great resources, visit www.library.collaboratorycareerhub.com
  continue reading
 
Data in Biotech is a fortnightly podcast exploring how companies leverage data to drive innovation in life sciences. Every two weeks, Ross Katz, Principal and Data Science Lead at CorrDyn, sits down with an expert from the world of biotechnology to understand how they use data science to solve technical challenges, streamline operations, and further innovation in their business. You can learn more about CorrDyn - an enterprise data specialist that enables excellent companies to make smarter ...
  continue reading
 
Artwork

1
The Climate Biotech Podcast

Homeworld Collective

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
Are you fascinated by the power and potential of biotechnology? Do you want to learn about cutting-edge innovations that can address climate change? The Climate Biotech Podcast explores the most pressing problems at the intersection of climate and biology, and most importantly, how to solve them. Hosted by Dan Goodwin, a neuroscientist turned biotech enthusiast, the podcast features interviews with leading experts diving deep into topics like plant synthetic biology, mitochondrial engineerin ...
  continue reading
 
Biotech—it's complicated. A successful product launch requires grit, determination, and clear direction. But let’s be real, the path to launch isn’t a straight one. There are curves, hard turns, and dead ends. Here’s the good news, you don’t have to navigate the complexities alone. Welcome to The Emerging Biotech Leader, where we help biotech leaders maximize the value of their therapeutics from clinical development to product launch.
  continue reading
 
Artwork

1
Mad Science: The Genetic Crossroad With Anna Kavanaugh

Anna Kavanaugh | Living Eden Media, LLC

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
Anna Kavanaugh hosts the weekly radio series, "Mad Science: The Genetic Crossroad." The program aims to raise awareness and provide education about genetically modified organisms (GMO), in the world food supply and the practices of the GM biotech industry. The series is dedicated to all issues surrounding GM foods, its usage and ramifications thereof. Anna is a writer, producer, journalist and advocate. She is the founder of the (AKCF) Anna Kavanaugh Charitable Foundation. Her original novel ...
  continue reading
 
Welcome to the Biotech Bytes podcast, where we sit down with Biotech and Pharma IT leaders to learn what's working in our industry. Steven Swan is the CEO of The Swan Group LLC. He has 20 years of experience working with companies and individuals to make long-term matches. Focusing on Information technology within the Biotech and Pharmaceutical industries has allowed The Swan Group to become a valued partner to many companies. Staying in constant contact with the marketplace and its trends a ...
  continue reading
 
Artwork

1
Say More

The Boston Globe

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Weekly
 
Big ideas and big debates, explained through intimate conversations with the compelling personalities who shape them. AI and biotech. Higher education and health care. Climate and sustainability. Politics and the media. Culture and culture wars. Hosted by Boston Globe columnist Shirley Leung.
  continue reading
 
Artwork
 
Careers in Discovery is your window into the world of Pharma & Biotech. Featuring interviews each week with leaders in Drug Discovery and R&D, you’ll learn about the careers of these influential figures, the work they are doing, how they got to where they are and what advice they’d give their younger selves. Brought to you by Singular: Building Brilliant Biotechs. Connect with us at: LinkedIn: https://www.linkedin.com/company/singular-biotech/ www.singular-biotech.com
  continue reading
 
Artwork

1
Syntax

Twin Strangers Productions

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
A science fiction, horror audio drama podcast that follows Silas Caldwell, a linguist, who finds himself employed by VINCULA, a biotech company with an unearthly set of artifacts in their possession. Alongside a team of scientists and explorers, Silas plunges into the world beyond the Breach, and is touched by terrors beyond his wildest dreams. This show is a full cast audio drama, and has adult themes and horror settings. Made by Twin Strangers Productions. Hosted by Pinecast
  continue reading
 
Burma | Chicago Scientist 🥼🧪🔬 Covering biotech, pharma, and healthcare companies shaping the world 🧬🏥🌎 Stream new episodes every THURSDAY! https://linktr.ee/maneadkhin #biotech #pharma #healthcare #podcast #petridishperspectives
  continue reading
 
Artwork

1
Genefitletics

Sushant Kumar

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
This podcast is hosted by biotech entrepreneur Sushant Kumar, Founder & CEO of Genefitletics. Through this exclusive health podcast, he addresses the information asymmetry in the preventive health space. He is currently building Genefitletics, which is a direct-to-customer Biotech company- that studies & analyses activities of single & multicellular microorganisms living on & inside human body to provide precision health interventions in order to eradicate epidemic of chronic diseases, cance ...
  continue reading
 
Artwork

4
Pathways in Life Science

North Star Scientific Inc.

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
We dive into the stories of people shaping life sciences and biotech. Each episode highlights scientists, professionals from the lab to the boardroom, entrepreneurs, and innovators—their career twists, key decisions, and impact. It’s packed with insights, advice, and inspiration for anyone curious about science-driven careers making a difference.
  continue reading
 
Artwork

1
Finding Genius Podcast

Richard Jacobs

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Weekly+
 
Podcast interviews with genius-level (top .1%) practitioners, scientists, researchers, clinicians and professionals in Cancer, 3D Bio Printing, CRISPR-CAS9, Ketogenic Diets, the Microbiome, Extracellular Vesicles, and more. Subscribe today for the latest medical, health and bioscience insights from geniuses in their field(s).
  continue reading
 
Loading …
show series
 
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. This morning, we're diving into a series of fascinating updates that underline the vibrant and ever-changing landscape of our industry.The J.P. Morgan Healthcare Conference recently set the stage for some intriguing d…
  continue reading
 
This is the 2026 BioTech Nation "5": Five Companies Ready to Make a Difference. We're highlighting 5 biotech companies with a special release of interviews in time for the 44th Annual J.P. Morgan Healthcare Conference right here in San Francisco. Hear all 5 interviews at https://www.biotechnation.com/jpm-2026-btn-5 On this episode of BioTech Nation…
  continue reading
 
🧬 The Biotech Startups Podcast is powered by Excedr—helping life science startups accelerate R&D and commercialization with founder-friendly equipment leasing. Skip the upfront costs, stay lean, and focus on breakthrough science. As a TBSP listener, you can get exclusive perks through Excedr’s partner network—special savings, promotions, and more. …
  continue reading
 
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, we're speaking with Kenneth Galbraith, CEO and Board Chair at Zymeworks, a biotech developing multispecific therapies internally and through partnerships with companies including Jazz Pharmaceuticals and BeOne Medicines (formerly BeiGene), J&J,…
  continue reading
 
Karl and Erum kick off 2026 by reviewing their 2025 forecasts—celebrating the wins (DeSci's rise, waste as a resource, AI-biology convergence) and acknowledging the misses (no biotech M&A boom, no quantum biology breakthrough yet). Then they unveil their boldest predictions for the year ahead: the first functional AI-composed genome entering produc…
  continue reading
 
Welcome to our first episode for 2026. Today, we're joined by Hakan Goker, Managing Director at M Ventures, the strategic corporate venture capital arm of Merck KGaA. With over two decades in biotech investing, Hakan has driven transformative deals in oncology, autoimmune diseases, and beyond, including standout 2025 investments like FoRx Therapeut…
  continue reading
 
January brings fresh biotech hiring budgets, energized hiring managers, and real momentum after a tough 2025. If you've been waiting for the right time to level up your biotech career, this is it. In this episode, you'll discover: Why January is the best month to apply for biotech jobs after a slow December How the December Networking Challenge hel…
  continue reading
 
Send us a text Welcome to your essential overview of the global biotech and pharmaceutical landscape for December 2025! This month was dominated by a surge in M&A activity and licensing deals. 🎧 Listen now, stay curious, and don’t forget to subscribe for new episodes! https://linktr.ee/maneadkhin #PetriDishPerspectives #BiotechNews #PharmaNews Supp…
  continue reading
 
In this episode of Data in Biotech, Ross Katz chats with Mitra Mosharraf, Chief Scientific Officer at HTD Biosystems, about how AI and machine learning are revolutionizing nanomedicine. They explore the use of AI in drug discovery, formulation, manufacturing, and clinical development, highlighting how data-driven strategies are improving safety, re…
  continue reading
 
Biotech stocks staged a dramatic turnaround in 2025, with the XBI well outpacing the S&P 500 despite concerns over leadership changes at the U.S. Food and Drug Administration, the Trump administration’s efforts to put constraints on drug pricing, and its broader cuts to health and science agencies. A pick-up in deal-making, along with falling inter…
  continue reading
 
Steve Grun is the Co-Founder and CEO of MNDL Bio, an Israeli startup that uses AI to design better DNA sequences for making proteins—helping companies produce up to 20 times more protein than traditional methods. Their tech takes the guesswork out of gene design for biotech and pharma companies developing new drugs, enzymes, and other biological pr…
  continue reading
 
In this episode, Gabriella Rubert joins the Biotech Connection Los Angeles team for a thoughtful conversation reflecting on her journey as a host of the Inside Biotech podcast. Together, they explore the challenges and rewards of science communication, the responsibility of making complex scientific topics accessible, and the impact storytelling ha…
  continue reading
 
This is a throwback to episode 484, a very important correction of their episode on glyphosate. With so much controversy around this compound it is critical to keep the information correct and consistent with a 50 year body of evidence when discussing risk and benefit. Veritassium made some mistakes, so here they are corrected so that you can parti…
  continue reading
 
A Year of Biotech Bytes: Reflections, Stories, and Honest Moments #biotechbytes #biotechpodcast #behindthemic This episode is a look back at the year, the lessons we learned, and the moments that shaped Biotech Bytes. Please visit our website to get more information: https://swangroup.net/ I’m joined by Mary Louise Smith, the voice, support, and go…
  continue reading
 
The Rare Pediatric Disease Priority Review Voucher (PPRV) program has been one of the few market-based incentives pushing biotech companies to develop treatments for children with rare conditions. But when its authorization lapsed in late 2024, the future of dozens of pediatric research programs was suddenly thrown into question. In this episode of…
  continue reading
 
Is the biotech industry truly out of its slump? Why are employers dropping coverage of weight loss drugs? And what will the hosts bake for the holidays? We discuss all that and more on this week's episode of "The Readout LOUD," the last episode of the year. We bring on Bruce Booth, partner at venture capital firm Atlas Venture, to reflect on everyt…
  continue reading
 
In this special episode, we sit down with Shuguang Zhang, Head of the Laboratory of Molecular Architecture in the MIT Media Lab and a mentor to countless biotech explorers. His personal story has at least one literal "1 in 100 Million" moment and demonstrates the power of curiosity, kindness, and always asking questions. We trace how Shuguang's stu…
  continue reading
 
Synopsis: This episode is proudly sponsored by Quartzy.Roivant Sciences CEO Matt Gline returns to Biotech 2050 for a deeply reflective conversation with host Rahul Chaturvedi on what it really takes to build a biotech company that lasts. From Roivant’s transformational $7B Pfizer-to-Roche deal to delivering registrational Phase 3 data in dermatomyo…
  continue reading
 
Loading …
Copyright 2026 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play